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Abstract 
Endosomolytic polymers can aid in the endosomal release of therapeutics to improve 
intracellular drug delivery. pH-responsive biomimetic pseudo-peptides were 
synthesised by grafting L-phenylalanine onto the pendant carboxylic acids of a 
polyamide, poly(L-lysine isophthalamide). PP-75 (stoichiometric L-phenylalanine 
grafting of 75 mol%) was determined to have the best endosomolytic property. The 
mean hydrodynamic size of PP-75 decreased with lower pH as the polymers adopted 
a more compact conformation due to protonation of acidic groups and increase in 
hydrophobicity. PP-75 was demonstrated to deliver model drugs effectively in three 
dimensional (3D) magnetic HeLa multicellular spheroids used as in vitro tumour 
models. These spheroids can be isolated easily and quickly by magnetic separation. 
Due to its relatively small size, PP-75 was able to penetrate from the exterior to the 
interior of these spheroids and was internalised by the cells in the spheroids. It could 
retain its pH-mediated membrane-lytic capability in 3D drug delivery by releasing 
internalised calcein from intracellular endosomes in the tumour models. Furthermore, 
cell viability results suggest that PP-75 showed no significant cytotoxicity towards 
cells in the spheroids. The pH-responsive PP-75 can potentially enhance the 
extracellular and intracellular delivery of therapeutics in tumours. 
 
Keywords: drug delivery; pH-responsive polymer; L-phenylalanine; pseudo-peptide; 
multicellular spheroids; magnetic separation 
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1. Introduction 
One of the main aims of drug delivery research is the efficient intracellular 
delivery of therapeutics, particularly macrodrugs such as proteins and nucleic acids. 
Mammalian cells usually internalise macromolecular prodrugs through endoctyosis 
which results in endosomal localisation. After cellular uptake, internalised drugs face 
several obstacles such as lysosomal degradation before they can reach their target 
organelles or cell nuclei [1]. To prevent lysosomal degradation, drugs entrapped in 
endosomes must be able to ‘escape’ into the cytosol before the endosomes fuse with 
lysosomes. One strategy for endosomal release is through membrane disruption using 
pH-responsive polymers [2]. These polymers can undergo pH-mediated coil-globule 
changes in conformation and this property enhances their membrane disruptive 
behaviour [3-7]. 
A class of biodegradable, pH-responsive polymers has been recently 
developed to mimic factors that enable efficient viral transfection. The parent polymer 
is a polyamide, poly(L-lysine isophthalamide), and hydrophobic amino acids were 
grafted onto its pendant carboxylic acid groups to manipulate its amphiphilicity and 
structure [8, 9]. Recent studies indicated that L-phenylalanine grafted polymers have 
vastly superior membrane-disruptive activity at endosomal pHs and could be used for 
intracellular drug delivery [10, 11]. 
 Another important aspect of drug delivery is the transport of drugs through 
extracellular barriers before they reach the cell surface. Penetration of 
chemotherapeutics is often a problem for efficacious cancer therapy [12]. Ideally, the 
drug should reach all cells in a tumour after leaving the vasculature. However, high 
interstitial pressure within tumours [13], diffusion limitations and the extracellular 
matrix [14] present significant obstacles to effective drug delivery. Therefore 
*Manuscript
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relatively high drug concentrations were frequently used to overcome these problems. 
This inevitably led to toxic side effects in patients [15]. 
Drug delivery systems serve to reduce the systemic toxicity by enhancing the 
delivery of therapeutics to specific diseased sites at a lower dose. However these 
systems are often studied using two dimensional (2D) cell monolayers which cannot 
reproduce the complex three dimensional (3D) environment in tissues or organs. To 
better model the actual in vivo conditions, 3D multicellular spheroids were developed 
and they have been used as avascular tumour models for evaluating small molecule 
[16] or nanoparticle [17, 18] delivery. Magnetic multicellular spheroids could be 
generated from magnetically labelled cells. These spheroids can be easily separated 
using magnetic separators and could be useful for various applications such as drug 
screening and toxicity assays [19-21].  
In this study, the relationship between pH and hydrodynamic size of L-
phenylalanine grafted polymers was examined. Furthermore, the potential of using 
these grafted polymers for drug delivery in 3D magnetic tumour spheroids was 
qualitatively and quantitatively assessed using confocal microscopy and flow 
cytometry respectively. The non-specific cytotoxicity of the polymers towards cells in 
the multicellular spheroids was evaluated as well. 
  
2. Materials and methods 
2.1. Materials 
2.1.1. Materials for polymer synthesis 
Isophthaloyl chloride, fluorescein 5-isothiocyanate (FITC), N,N’-
dicyclohexylcarbodiimide (DCC), 4-dimethylaminopyridine (DMAP), N,N’-
dimethylformamide (DMF), potassium carbonate and  triethylamine were purchased 
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from Sigma-Aldrich (Dorset, UK). L-lysine methyl ester dihydrochloride and dimethyl 
sulfoxide (DMSO) were obtained from Fisher (Loughborough, UK). L-phenylalanine 
methyl ester hydrochloride was purchased from Alfa Aesar (Heysham, UK).  
 
2.1.2. Materials for cell culture and drug delivery studies 
Accutase®, biotinamidohexanoic acid N-hydroxysuccinimide ester (BiotinSE), 
calcein, Dulbecco’s modified Eagle medium (DMEM), Dulbecco’s phosphate 
buffered saline (D-PBS), penicillin-streptomycin solution (10,000 U mL-1 penicillin, 
10 mg mL-1 streptomycin) and trypsin–EDTA solution (0.5 g L-1 porcine trypsin and 
0.2 g L-1 EDTA·4Na) were purchased from Sigma-Aldrich (Dorset, UK). Streptavidin 
MagneSpheres paramagnetic particles (1 mg mL-1) were purchased from Promega 
(Southampton, UK). Foetal bovine serum (FBS) and propidium iodide (Invitrogen 
P3566, 1 mg mL-1) were purchased from Invitrogen (Paisley, UK). 
 
2.2. Polymer synthesis and characterisation 
PP-75 was synthesised by grafting L-phenylalanine onto poly(L-lysine 
isophthalamide) according to the previously reported procedure [8, 10, 22-24] using 
DCC as a coupling agent and DMAP as a hyperacylation catalyst [25, 26]. Here, the 
number denotes the stoichiometric molar percentage of L-phenylalanine relative to the 
pendant carboxylic acid groups of poly(L-lysine isophthalamide) ([NH2]/[COOH]). 
FTIR spectra of poly(L-lysine isophthalamide) and PP-75 were recorded on a Nicolet 
Nexus FTIR spectrometer (Thermo Fisher Scientific, USA). FTIR (acid form): 3294 
cm-1 (N–H str and O–H str), 1720 cm-1 (C=O acid str), 1634 cm-1 (amide band I), 
1528 cm-1 (amide band II), 1274, 1088 cm-1 (C–O str). The molecular weight and 
polydispersity of poly(L-lysine isophthalamide) (Mw = 35,700, polydispersity = 1.99) 
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were determined using an aqueous gel permeation chromatography (GPC) system 
(Viscotek, UK), which was calibrated with polyethylene glycol standards. 1H-NMR 
spectra of poly(L-lysine isophthalamide) and its derivative polymer PP-75 were 
obtained in d6-DMSO on a Bruker Advance 500 MHz NMR spectrometer (Bruker 
Biospin GmbH, Germany). The degree of L-phenylalanine grafting of PP-75 (63.2 
mol%) was measured from its 1H-NMR spectrum, and used to calculate its molecular 
weight (Mn = 24.9 kDa). 
  FITC-NH-(CH2)2-NH2 was prepared from reaction of FITC with ethylene 
diamine using dibutyltin dilaurate as a catalyst. The fluorescent polymer PP-75-FITC 
(1 mol% FITC) was prepared by coupling FITC-NH-(CH2)2-NH2 to the carboxylic 
acid groups of PP-75 using standard DCC/DMAP mediated coupling techniques [10].  
 
2.3. Dynamic light scattering 
The hydrodynamic diameters of PP-75 were investigated using a 
PDDLS/Batch dynamic light scattering (DLS) platform equipped with a PD2000DLS 
detector (Precision Detectors, USA). The polymer aqueous solutions at 5 mg mL-1 
were prepared in 0.1 M buffers at specific pHs and allowed to equilibrate for 48 h. 
The samples were filtered through 0.45 Pm pore size filters, and then the 
measurements were conducted in a 1.0 mL quartz cuvette using a diode laser of 800 
nm at a scattering angle of 90°. 
 
2.4. Spheroid culture 
HeLa human cervix adenocarcinoma cells were cultured in DMEM 
supplemented with 10% FBS, 100 U mL-1 penicillin and 100 μg mL-1 streptomycin 
and maintained in a 5% CO2 humidified atmosphere at 37°C. Magnetically labelled 
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HeLa cells were prepared using a previously developed method [27]. Briefly, HeLa 
cells were treated with 750 μM BiotinSE in D-PBS at room temperature for 30 min. 
0.05 mg mL-1 streptavidin paramagnetic particles were added to biotinylated HeLa 
cells and vortexed for 15 s to ensure mixing of particles and cells. To generate 
magnetic spheroids [19], 15 μL drops containing 500 magnetically labelled HeLa 
cells each were added onto a culture dish cover lid. The lids were then inverted and 
placed on top of the dish. 10 mL of PBS was added to prevent evaporation of the 
hanging drops which were cultured in a 5% CO2 humidified atmosphere at 37°C. Six 
day old spheroids were harvested for further studies as described below. 
 
2.5. 3D drug delivery to spheroids 
For the concentration-dependent studies using PP-75-FITC, HeLa spheroids 
were treated with different PP-75-FITC concentrations in serum-free DMEM for 1 h 
at 37°C. For the time-dependent studies, HeLa spheroids were treated with 1 mg mL-1 
PP-75-FITC for different durations. PP-75-FITC was then removed and the spheroids 
were washed with D-PBS and complete DMEM was added. The spheroids were then 
further incubated at 37°C for 3.5 h before they were analysed using either confocal 
microscopy or flow cytometry as depicted below.  
For the study using calcein as a model drug, HeLa spheroids were treated with 
different calcein concentrations with or without PP-75 (1 mg mL-1) in serum-free 
DMEM for 1 h at 37°C. Thereafter the spheroids were further incubated for 3.5 h at 
37°C in complete DMEM before they were analysed using either confocal 
microscopy or flow cytometry. 
 
2.6. Confocal laser scanning microscopy 
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After the spheroids were treated according to the protocol described above, 
they were placed on 35 mm glass-bottom culture dishes (MatTek) and imaged using a 
Leica SP5 confocal laser scanning microscope. Both the PP-75-FITC and calcein 
were excited using the 488 nm laser line. Optical sections (1 μm thick) were imaged 
until the fluorescence was lost. These images were then compiled into a 3D 
projection. 
 
2.7. Flow cytometry 
40–50 six day old HeLa spheroids were used for each experimental condition 
as described above. Thereafter HeLa spheroids were separated using a Dynal MPC-S 
magnetic particle concentrator (Invitrogen). After D-PBS wash, the spheroids were 
enzymatically dissociated with Accutase®. The dissociated individual cells were 
further washed with D-PBS and resuspended in D-PBS with 2.5 μg mL-1 propidium 
iodide. The cells were then analysed by flow cytometry (BD FACSCan). 10,000 
events were recorded and the data was analysed using CellQuest. FITC fluorescence 
intensities of 20 arbitrary units (a.u.) and above were regarded as FITC-positive (+), 
as the control sample recorded fluorescence intensities of less than 20 a.u. Cell 
viability was assessed by gating cell populations showing negligible propidium iodide 
fluorescence. 
 
3. Results and discussion 
 The hydrodynamic size of PP-75 was measured using DLS and it showed a pH 
dependent size change. At pH 6.0, PP-75 has a mean hydrodynamic diameter of 17 
nm (Fig. 1a). The hydrodynamic size increases as the pH increases with a mean 
diameter of 37 nm at the physiological pH of 7.4, as shown in Fig. 1b. This pH 
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dependent behaviour occurred as PP-75 alters its conformation according to pH 
changes. The hydrophobicity of the polymer increases as the pH decreases with the 
protonation of free carboxylic acid groups and growing hydrophobic interactions 
between the grafted L-phenylalanine, resulting in an even more compact structure [8].  
 PP-75, the L-phenylalanine grafted polymer with the most promising property 
for endosomal membrane disruption [10], was selected for 3D delivery studies in 
magnetic HeLa tumour spheroids. PP-75 labelled with fluorescein 5-isothiocyanate 
(PP-75-FITC) was incubated with magnetic HeLa multicellular spheroids and 
confocal microscopy was used to study the distribution of the fluorescent polymer in 
the spheroids. Fig. 2 shows that the 3D delivery of PP-75-FITC is dependent on both 
polymer concentration and incubation duration. More polymers can be delivered into 
the spheroids when there is a higher polymer concentration or longer incubation time, 
as shown by the stronger fluorescence. The images in the Y-Z axis show that the 
polymers were able to penetrate into the spheroids.  
 The use of confocal microscopy to visualise polymer penetration into the 
spheroids suffers from an imaging depth limitation due to the loss of fluorescent 
signal and increased background at depths greater than 100–200 μm [28]. To 
overcome this constraint and to obtain a more quantitative analysis, flow cytometry 
was used for further studies. HeLa spheroids which have been treated with PP-75-
FITC were enzymatically dissociated into individual cells and the cells were then 
analysed using a flow cytometer.  
Quantitative data in Fig. 3 further proved that the 3D delivery of PP-75, shown 
as the proportion of FITC positive cells and mean FITC fluorescence intensity of the 
cell population, is dependent on both the polymer concentration and incubation 
duration with the polymer. Compared to HeLa cells grown as a monolayer, higher 
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polymer concentrations were needed to achieve a significant distribution in the HeLa 
spheroids. When HeLa cell monolayers were treated with 0.05 mg mL-1 of PP-75-
FITC for 1 h, 74% of cells had taken up the fluorescent polymer. With increasing 
polymer concentration to 0.1 mg mL-1, almost all monolayer cells (97%) were FITC-
positive. As comparison, treatment with 0.05 mg mL-1 of PP-75-FITC for 1 h only 
achieved 19% cellular uptake of the polymer in HeLa spheroids. The proportion of 
FITC-positive cells was saturated at 93% with increasing polymer concentration up to 
5 mg mL-1 (Fig. 3a). When the incubation duration with PP-75-FITC (1 mg mL-1) was 
extended from 15 min to 2 h, the proportion of FITC-positive cells in the spheroids 
increased gradually from 34% to 83% (Fig. 3 c). There is less difficulty with diffusion 
for cell monolayers, while the delivery of polymers into the spheroids faced diffusion 
limitations and additional barriers such as the extracellular matrix [14]. Therefore 
higher polymer concentrations are required for efficient delivery in spheroids. This is 
likely the same situation for effective polymer delivery in vivo.  
Cell viability in the multicellular spheroids was analysed by flow cytometry 
using the propidium iodide exclusion assay to evaluate the non-specific cytotoxicity 
of PP-75-FITC towards the cells in the spheroids. Propidium iodide can enter non-
viable cells with permeable membranes and binds with intracellular nucleic acids by 
intercalation. As shown in Fig. 4a, the polymer was not drastically toxic to HeLa cells 
at concentration up to 4 mg mL-1 after 1 h of treatment. Fig. 4b shows that PP-75-
FITC (1 mg mL-1) only had a relatively low level of cytotoxic effect with extended 
incubation time to 2 h. These results suggest that PP-75 will probably have a similar 
toxicity profile, since the degree of FITC labelling (1 mol%) is kept low to avoid 
significant modulation of the polymer properties and fluorescence quenching [10]. 
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To study whether PP-75 still retains its membrane-lytic activity in 3D 
delivery, magnetic HeLa spheroids were treated with free calcein (as a model drug) 
and PP-75. Calcein, which has been internalised by cells, is trapped within endosomes 
and undergo self-quenching with reduced fluorescence when excited with lasers. This 
quenching effect could be reduced when calcein is released from the endosomes and 
is freely dispersed within the cytoplasm [29].  
The confocal images (Fig. 5c, d) showed that more calcein was released from 
endosomes when PP-75 was co-incubated with it. Flow cytometric analysis further 
confirmed that PP-75 was able to help attain higher intracellular calcein fluorescence 
within the spheroids (Fig. 6). What is even more significant is that PP-75 (with 2 mg 
mL-1 calcein) was able to achieve higher calcein fluorescence compared to the 4 mg 
mL-1 free calcein control. This could mean that lower drug concentrations can be used 
in polymer-mediated delivery. Non-specific cytotoxicity and side effects of drugs 
could then be minimised.  
In the study above, PP-75 was able to penetrate efficiently into the 3D 
multicellular spheroids and achieve a reasonable concentration in the spheroids (Fig. 2 
and 3). When the polymers were internalised, they were able to disrupt endosomal 
membranes for effective intracellular release of endocytosed calcein (Fig. 5 and 6). 
The transport of PP-75 in the spheroids might be less obstructed due to its small size 
(Fig. 1), which makes it easier to diffuse through the extracellular space. Studies have 
shown that penetration of nanoparticles into the core of multicellular spheroids was 
limited to particles smaller than 100 nm [17, 18]. It was demonstrated that adeno-
associated viral vectors (~25 nm in diameter) can penetrate human solid tumour tissue 
in vivo more efficiently than adenoviral vectors (~100 nm in diameter) [30], which 
could be attributed at least in part to these differences in particle size. In addition, 
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grafting with the hydrophobic amino acid L-phenylalanine can facilitate effective cell 
surface binding, which is necessary for uptake of the polymer. 
Fig. 1 shows that PP-75 formed a compact structure (37 nm in diameter at pH 
7.4) stabilised by hydrophobic association. The mean hydrodynamic diameters of 
these polymeric nanoparticles gradually reduced to 17 nm with pH decreasing to 6.0. 
It is known that in vivo tumours have lower extracellular pH than normal tissues [31]. 
Moreover, pH gradients exist within spheroids and tumours with the pH decreasing 
from the exterior to the interior [32]. As PP-75 migrated through the spheroids, it 
experienced decreasing pH and could undergo further size reduction. This could have 
actually aided in the penetration of PP-75 towards the core of the multicellular 
spheroids and resulted in a higher proportion of cells which internalised the polymer.  
This work represents the first time that magnetic multicellular spheroids were 
used as tumour models in drug delivery research. These spheroids can be easily 
separated using a magnetic separator within a few seconds without the need for 
centrifugation. This allows for facile separation of spheroids after incubation with 
drugs or drug delivery systems for further examination using other analytical 
techniques such as confocal microscopy and flow cytometry used in this study. As 
mentioned previously, the magnetic property of these spheroids will make them 
suitable for large scale or high throughput studies requiring large amounts of 
spheroids and quick separation for subsequent investigations [19]. Furthermore, 
recent studies also showed that 3D multicellular spheroids have great potential for 
predicting in vivo experimental results in drug delivery [33]. 
  
4. Conclusions  
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In this current study, it was shown that the pH-responsive, biodegradable and 
biomimetic polymers grafted with L-phenylalanine have significant potential to be 
used to deliver therapeutics. In particular, the endosomolytic polymer, PP-75 (63.2 
mol% L-phenylalanine, Mn = 24.9 kDa), shows a pH-dependent change in its 
hydrodynamic size. The effective penetration of PP-75 into tumour models and its 
ability to release internalised model drugs within cells in tumour spheroids suggest 
that it could be studied in in vivo or clinical research to further evaluate and realise its 
potential for delivering therapeutics to tumours. 
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Figure Captions 
 
Figure 1. Mean hydrodynamic diameters of PP-75 at 5 mg mL-1 in 0.1 M buffers. (a) Size distribution at 
pH 6.0. (b) pH-dependent mean hydrodynamic diameters. Error bars represent standard deviations of 
four samples. 
 
Figure 2. Confocal microscopy images of HeLa spheroids treated with PP-75-FITC at (a, b) 0.05 mg 
mL-1 for 1 h, (c, d) 4 mg mL-1 for 1 h, (e, f) 1 mg mL-1 for 2 min and (g, h) 1 mg mL-1 for 2 h. Samples 
were imaged after 3.5 h further incubation. (a, c, e, g) show the image in the X-Y axis, while (b, d, f, h) 
show the image in the Y-Z axis. 
 
Figure 3. Flow cytometric analysis of cellular uptake of PP-75-FITC in HeLa multicellular spheroids. (a, 
b) Concentration-dependent uptake of PP-75-FITC after treatment for 1 h. (c, d) Time-dependent uptake 
of PP-75-FITC at 1 mg mL-1. Samples were tested after 3.5 h further incubation. (a, c) show the 
proportion of FITC-positive cells, while (b, d) show the relative mean fluorescence intensity (MFI) of cell 
population expressed in arbitrary units (a.u.). Relative MFI = (MFIsample/MFIcontrol). 40-50 spheroids were 
used for each experimental condition and the spheroids were enzymatically dissociated for subsequent 
flow cytometric analysis.  
 
Figure 4. Concentration- and time-dependent cell viabilities of HeLa spheroids treated with PP-75-FITC. 
(a) PP-75-FITC concentration-dependent studies. Spheroids were treated with various concentrations of 
PP-75-FITC for 1 h with 3.5 h further incubation in fresh complete culture media. (b) PP-75-FITC 
treatment duration-dependent studies. Spheroids were treated with 1 mg mL-1 PP-75-FITC for various 
durations with 3.5 h further incubation in fresh complete culture media. Relative cell viabilities were 
expressed in percentage based on the control without polymer treatment. 40-50 spheroids were used for 
each experimental condition and the spheroids were enzymatically dissociated for subsequent flow 
cytometric analysis using the propidium iodide exclusion assay.  
 
Figure 5. Confocal microscopy images of HeLa spheroids treated with (a, b) 2 mg mL-1 calcein for 1 h, 
and (c, d) 2 mg mL-1 calcein with 1 mg mL-1 PP-75 for 1 h. Samples were imaged after 3.5 h further 
incubation. (a, c) show the image in the X-Y axis, while (b, d) show the image in the Y-Z axis. 
 
Figure 6. Flow cytometric analysis of cellular uptake of calcein and PP-75 in HeLa spheroids. Spheroids 
were treated with various concentrations of calcein with or without PP-75. Samples were tested after 3.5 
Captions
h further incubation. Relative mean fluorescence intensity (MFI) of cell population was expressed in 
arbitrary units (a.u.). Relative MFI = (MFIsample/MFIcontrol). 40-50 spheroids were used for each 
experimental condition and the spheroids were enzymatically dissociated for subsequent flow cytometric 
analysis. 
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Supplementary Data 
 
 
 
Fig. S1  Flow cytometric analysis of cellular uptake of PP-75-FITC in HeLa cell 
monolayers. Samples were treated with PP-75-FITC for 1 h and tested after 3.5 h 
further incubation. (a) Proportion of FITC-positive cells. (b) Relative mean 
fluorescence intensity (MFI) of cell population expressed in arbitrary units (a.u.). 
Relative MFI = (MFIsample/MFIcontrol).  
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